Introduction: Pseudomonas aeruginosa is the most commonly isolated pathogen in
bronchiectasis and is associated with worse outcomes. Eradication treatment is …

Bronchiectasis is a complex and heterogeneous inflammatory chronic respiratory disease
with an unknown cause in around 30–40% of patients. The presence of airway infection …

Background International guidelines recommend airway clearance management as one of
the important pillars of bronchiectasis treatment. However, the extent to which airway …

Respiratory health has become a prevailing priority amid the diverse global health
challenges that the 21st century brings, due to its substantial impact on individuals and …

Bronchiectasis is a chronic respiratory disease characterised by permanent enlargement of
the airways associated with cough, sputum production and a history of pulmonary …

Bronchiectasis, originating from the Greek words bronkhia (“airway”) and ektasis
(“distortion”), is a permanent, irreversible airway dilatation described in 1819 by René …

Background A validated 4-point sputum colour chart can be used to objectively evaluate the
levels of airway inflammation in bronchiectasis patients. In the European Bronchiectasis …

Extract Bronchiectasis is receiving increased awareness from clinicians, researchers and
stakeholders. However, despite the development of international and national guidelines in …

According to a recent statement from the Global Alliance for Chronic Diseases (Lung
Diseases group)[1] the effective management of chronic lung disease requires timely and …

In this review, early career and senior members of Assembly 5 (Airway Diseases, Asthma,
COPD and Chronic Cough) present key recent findings pertinent to airway diseases that …